Miami, FLCIK 13250834 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
33 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Aldeyra Therapeutics Inc | 5.48M | $28.36M | 13.0% | 0 | Held |
| 2 | Biohaven Pharmaceutical Holding Co Ltd | 2.33M | $26.29M | 12.1% | +1.43M | Added |
| 3 | Nuvation Bio Inc | 1.50M | $13.43M | 6.2% | +473.6K | Added |
| 4 | Avadel Pharmaceuticals PLC |
| 600.0K |
| $12.93M |
| 5.9% |
| 0 |
| Held |
| 5 | Spdr Gold Tr | 32.0K | $12.68M | 5.8% | 0 | Held |
| 6 | Royal Gold Inc | 52.8K | $11.73M | 5.4% | +43.8K | Added |
| 7 | Kinross Gold Corp | 410.0K | $11.55M | 5.3% | 0 | Held |
| 8 | Entera Bio Ltd | 5.88M | $11.41M | 5.2% | 0 | Held |
| 9 | Meiragtx Hldgs PLC | 1.25M | $9.94M | 4.6% | 0 | Held |
| 10 | Seabridge Gold Inc | 317.0K | $9.38M | 4.3% | 0 | Held |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio